Real-world evidence effect of budesonide+formoterol Spiromax on patients with asthma and chronic obstructive pulmonary disease in Sweden

Background and Objective: Despite improved asthma and chronic obstructive pulmonary disease (COPD) management, treatment remains inadequate in many patients. Understanding the impact of current treatment in settings outside of controlled trials would add important clinical decision-making informatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Janson, Christer, Benhaddi, Hicham, Törnblom, Michael, Uhde, Milica, Johansson, Gunnar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6758718/
https://www.ncbi.nlm.nih.gov/pubmed/31579437
http://dx.doi.org/10.1080/20018525.2019.1660565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6758718/
https://www.ncbi.nlm.nih.gov/pubmed/31579437
http://dx.doi.org/10.1080/20018525.2019.1660565

Ejemplares similares